CHMP Favors EU Approval of Evrysdi as 1st Oral, At-home SMA Treatment & Discussing GI Issues

from The Spinal Muscular Atrophy Podcast with Kevin Schaefer · host SMA News Today

SMA News Today’s multimedia associate, Price Wooldridge, discusses the Committee for Medicinal Products for Human Use (CHMP) approval of Evrysdi as the first oral, at-home Spinal Muscular Atrophy (SMA) treatment.DeAnn Runge talks about her hesitancy to meet with a dietician to discuss GI issues she’s been dealing with. Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/

Episode metadata supplied by the publisher feed · Published Mar 12, 2021

Embed this episode

Attribution link and audio player

Ready to play

CHMP Favors EU Approval of Evrysdi as 1st Oral, At-home SMA Treatment & Discussing GI Issues

0:00 8:31

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Spinal Muscular Atrophy Podcast with Kevin Schaefer?

This episode is 8 minutes long.

When was this The Spinal Muscular Atrophy Podcast with Kevin Schaefer episode published?

This episode was published on March 12, 2021.

Can I download this The Spinal Muscular Atrophy Podcast with Kevin Schaefer episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!